Moreover, RGS5 deficiency has been reported to be associated with tumor progression in lung cancer [14], while RGS6 exerts its tumor suppressor function via G protein-independent signaling mechanisms in breast cancer [15]. The gene discussed is RGS5; the disease is neoplasm.